210 related articles for article (PubMed ID: 23324508)
21. Are family physicians using the CHADS₂score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?
Klein D; Levine M
Can Fam Physician; 2011 Aug; 57(8):e305-9. PubMed ID: 21841094
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
Mentias A; Shantha G; Chaudhury P; Vaughan Sarrazin MS
JAMA Netw Open; 2018 Sep; 1(5):e182870. PubMed ID: 30646182
[TBL] [Abstract][Full Text] [Related]
23. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries.
Baik SH; Hernandez I; Zhang Y
J Manag Care Spec Pharm; 2016 Mar; 22(3):281-92. PubMed ID: 27003558
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.
Piccini JP; Mi X; DeWald TA; Go AS; Hernandez AF; Curtis LH
Heart Rhythm; 2012 Sep; 9(9):1403-8. PubMed ID: 22537885
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
27. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
28. Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation.
Yang L; Brooks MM; Glynn NW; Zhang Y; Saba S; Hernandez I
Am J Cardiol; 2020 Jul; 126():29-36. PubMed ID: 32359718
[TBL] [Abstract][Full Text] [Related]
29. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
Gage BF; Waterman AD; Shannon W; Boechler M; Rich MW; Radford MJ
JAMA; 2001 Jun; 285(22):2864-70. PubMed ID: 11401607
[TBL] [Abstract][Full Text] [Related]
30. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
Oldgren J; Alings M; Darius H; Diener HC; Eikelboom J; Ezekowitz MD; Kamensky G; Reilly PA; Yang S; Yusuf S; Wallentin L; Connolly SJ;
Ann Intern Med; 2011 Nov; 155(10):660-7, W204. PubMed ID: 22084332
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation anticoagulation care in a large urban family medicine practice.
Valentinis A; Ivers N; Bhatia S; Meshkat N; Leblanc K; Ha A; Morra D
Can Fam Physician; 2014 Mar; 60(3):e173-9. PubMed ID: 24627401
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI
Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
35. CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin.
Wetmore JB; Yan H; Herzog CA; Weinhandl E; Reyes JL; Roetker NS
Am J Kidney Dis; 2021 Aug; 78(2):180-189. PubMed ID: 33421454
[TBL] [Abstract][Full Text] [Related]
36. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
Go AS; Hylek EM; Borowsky LH; Phillips KA; Selby JV; Singer DE
Ann Intern Med; 1999 Dec; 131(12):927-34. PubMed ID: 10610643
[TBL] [Abstract][Full Text] [Related]
37. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry).
Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL;
Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665
[TBL] [Abstract][Full Text] [Related]
38. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
[TBL] [Abstract][Full Text] [Related]
39. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.
Birman-Deych E; Radford MJ; Nilasena DS; Gage BF
Stroke; 2006 Apr; 37(4):1070-4. PubMed ID: 16528001
[TBL] [Abstract][Full Text] [Related]
40. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
